Global pharmaceutical company Pfizer (NYSE:PFE) will be announcing earnings results this Tuesday before market open. Here’s ...

These five large-cap value dividend stocks look poised to provide some second-half gains with steady ultra-high-yield ...

Despite this dip, the stock is still up 25% over the last month—significantly outpacing the S&P 500’s modest 1.2% increase.

Medication company Viatris (NASDAQ:VTRS) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, but sales fell by ...

Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read ...

Palantir stock surges in pre-market after crushing earnings estimates, boosting Nasdaq 100 and tech stock forecasts across US ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is currently conducting a post-marketing surveillance study ...

Discover CDL's high dividend yields, low volatility, and defensive strategy. Ideal for income-focused investors seeking ...

Disappointing jobs data and new tariffs shake US markets United States (US) stock markets fell on Friday night as investors ...

Archer Daniels Midland logged lower profit and revenue in the second quarter, hurt by what Chief Executive Juan Luciano called a challenging environment. Yum Brands logged higher profit and sales in ...

XOMA Royalty Corporation is to buy fellow US firm LAVA Therapeutics for $1.16 to $1.24 per share in cash, plus a contingent value right (CVR), the companies announced Monday.

The FTSE 100 edged down on Friday on a mixed day for European equities despite new optimism about an end to the war between ...